Global selection of Plasmodium falciparum virulence antigen expression by host antibodies by Greg, Fegan
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in:
Scientific Reports
                               
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa26546
_____________________________________________________________
 
Paper:
Abdi, A., Warimwe, G., Muthui, M., Kivisi, C., Kiragu, E., Fegan, G. & Bull, P. (2016).  Global selection of Plasmodium
falciparum virulence antigen expression by host antibodies. Scientific Reports, 6(1)
http://dx.doi.org/10.1038/srep19882
 
 
 
 
 
 
Released under the terms of a Creative Commons Attribution 4.0 International License (CC-BY). 
 
_____________________________________________________________
  
This item is brought to you by Swansea University. Any person downloading material is agreeing to abide by the terms
of the repository licence. Copies of full text items may be used or reproduced in any format or medium, without prior
permission for personal research or study, educational or non-commercial purposes only. The copyright for any work
remains with the original author unless otherwise specified. The full-text must not be sold in any format or medium
without the formal permission of the copyright holder.
 
Permission for multiple reproductions should be obtained from the original author.
 
Authors are personally responsible for adhering to copyright and publisher restrictions when uploading content to the
repository.
 
http://www.swansea.ac.uk/library/researchsupport/ris-support/ 
 1Scientific RepoRts | 6:19882 | DOI: 10.1038/srep19882
www.nature.com/scientificreports
Global selection of Plasmodium 
falciparum virulence antigen 
expression by host antibodies
Abdirahman I. Abdi1,2, George M. Warimwe4,5, Michelle K. Muthui1, Cheryl A. Kivisi1, 
Esther W. Kiragu1, Gregory W. Fegan1,3 & Peter C. Bull1,3,†
Parasite proteins called PfEMP1 that are inserted on the surface of infected erythrocytes, play a key role 
in the severe pathology associated with infection by the Plasmodium falciparum malaria parasite. These 
proteins mediate binding of infected cells to the endothelial lining of blood vessels as a strategy to avoid 
clearance by the spleen and are major targets of naturally acquired immunity. PfEMP1 is encoded by 
a large multi-gene family called var. Mutually-exclusive transcriptional switching between var genes 
allows parasites to escape host antibodies. This study examined in detail the patterns of expression of 
var in a well-characterized sample of parasites from Kenyan Children. Instead of observing clear inverse 
relationships between the expression of broad sub-classes of PfEMP1, we found that expression of 
different PfEMP1 groups vary relatively independently. Parasite adaptation to host antibodies also 
appears to involve a general reduction in detectable var gene expression. We suggest that parasites 
switch both between different PfEMP1 variants and between high and low expression states. Such a 
strategy could provide a means of avoiding immunological detection and promoting survival under high 
levels of host immunity.
Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a diverse family of proteins that are inserted 
into the surface of P. falciparum infected erythrocytes (IE). PfEMP1 plays an important role in malaria pathol-
ogy by mediating cytoadhesion of parasite IE to various host receptors including CD361,2, Intercellular adhesion 
molecule–1(ICAM-13), endothelial protein C receptor (EPCR)4 on the vascular endothelial cells and complement 
receptor (CR1)5,6 on erythrocytes7,8. Cytoadhesion of IE in the deep microvasculature allows parasites to avoid 
passage through the spleen where they would normally be removed from circulation9. When the parasite burden 
is high, this parasite survival strategy causes vascular occlusion contributing to the impaired perfusion thought to 
be the main cause of the distinct pathology associated with infections by this species of malaria parasite10.
PfEMP1 is encoded by a multi-gene family called var11–13. Each parasite genome contains approximately 60 
var genes, which are expressed in a mutually exclusive manner14. Switches in var gene expression allow the par-
asite to evade host immunity and prolong infection by evading antibody response13,15,16. Parasites that survive 
within the host are those that express PfEMP1 variants corresponding to gaps in the endogenous repertoire of 
host antibodies17,18.
Despite their immense molecular diversity, mainly generated through recombination events19–24, var genes can 
be classified into three major groups, A, B, and C according to sequence features found in their 5′ un-translated 
region14,25. These groups are broadly associated with the structural organization and size of the protein, with 
group A PfEMP1 tending to be longer than non-group A PfEMP126. Recently a functional classification based 
on the presence of commonly occurring combinations of specific Duffy binding-like (DBL) and cysteine-rich 
inter-domain region (CIDR) domains called domain cassettes (DCs) was described27.
Epidemiological data suggest that the risk of severe disease declines more rapidly than mild malaria as chil-
dren grow older28,29. This more rapid acquisition of immunity to severe malaria as compared to mild malaria has 
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been suggested to be as a result of a limitation in the diversity of important immune targets in P. falciparum30,31. 
Early serological work suggests the existence of PfEMP1 subgroups with limited diversity that are preferentially 
expressed by parasites causing infections in children with low immunity31–34.
Various studies have attempted to profile the var genes expressed by clinical P. falciparum isolates from chil-
dren diagnosed with severe and mild malaria35–41. However, different results have been obtained from these stud-
ies. This is potentially due to differences in the methods used to measure var expression. Previously, we used 
an expressed sequence tag (EST) approach using DBLα -tag amplification and sequencing to determine the var 
expression profile of clinical isolates38. With this method we found that the proportion of “group A-like” var genes 
expressed by the infecting parasites was positively associated with severe malaria and negatively associated with 
host antibodies present at the time of infection38,42. This supports the existence of PfEMP1 subsets with limited 
diversity30–32. This result was consistent with other studies employing a similar EST approach36,43.
Other investigators have used real-time qPCR primers designed to quantify more directly the transcript abun-
dance of var genes belonging to group A, B, and C or specific domain cassettes, relative to the expression of two 
metabolic genes35,37,40,41. These studies found that severe malaria is associated with the transcript quantity of 
group A, B and subsets of group A and B var genes containing domain cassette 13 and 835,37,40,41. In one study, 
the transcript quantity of group C var genes was associated with severe malaria, particularly cerebral malaria39. 
Overall, the qPCR approach suggests that severe malaria is associated with the expression of multiple PfEMP1 
subsets.
Two parasite encoded histone deacetylases commonly known as Pfsir2a and Pfsir2b have been linked to differ-
ential regulation of var gene expression44,45. In a recent study on clinical isolates, expression levels of Pfsir2a and 
Pfsir2b were associated with what was described as a “dysregulation” of var gene expression41.
Since these various studies were conducted in different laboratories and on samples from different geograph-
ical areas, it is unclear whether parasites vary considerably between populations or whether the EST and qPCR 
approaches are providing different kinds of information.
To help resolve apparently conflicting results obtained from different studies, we brought together qPCR and 
EST approaches within a single dataset. We also analysed the expression of Pfsir2a, Pfsir2b together with two 
markers of gametocyte commitment, Pfap2-g46 and Pfs1647.
We discuss how, despite apparent discrepancies seen previously between qPCR and EST, these approaches are 
highly consistent with one another but provide different kinds of information. We show that both global expres-
sion of var genes and expression of PfSir2a by the infecting parasite population is negatively associated with the 
breadth of host antibodies against the IE surface carried at the time of disease. We suggest that, in addition to 
switching between different PfEMP1 types, the parasite regulates the quantity of PfEMP1 on the IE globally as an 
additional immune evasion strategy.
Results and Discussion
To understand how PfEMP1 expression by the infecting parasite population is modified by host immunity at the 
time of infection, we compared var gene expression profiles and parasite IE phenotypes from parasites isolated 
from children with malaria attending Kilifi County Hospital in Kenya. We used three approaches: 1) an EST 
approach37,38,40 that gives low resolution information about the proportion of expressed var sequence tags sam-
pled from each isolate falling in broadly defined var classes,“cys2” and a subset of cys2 called “Group A-like”48. 2) 
We used qPCR to estimate what we will call the “transcript quantity” of each of several var gene classes relative 
to two housekeeping genes40 (primers used are listed in Table S1). 3) As an equivalent measure of the EST from 
this qPCR data, we obtained what we will call the “proportional expression” of each var gene subset by calculating 
expression of each var gene class as a proportion of the measured total detectable var transcript.
qPCR and EST approaches are consistent. The following observations demonstrated that qPCR and 
EST approaches to measuring var gene expression are consistent.
First, in line with previous studies42,49, both the proportional expression (gpA_prop) and the transcript 
quantity of group A var genes (gpA1 & gpA2) were positively associated with rosetting (Fig. 1a and Fig. 1b 
respectively).
Second, proportional expression estimated through qPCR was highly correlated with equivalent proportions 
estimated by EST sequencing (Fig. 1c). Specifically, 1) proportional expression of group A var genes (gpA_prop) 
was positively correlated with group A-like expression measured using EST (Figs. 1c) and 2) proportional expres-
sion of group B and C var genes (b1_prop, c2_prop, and bc_prop) were negatively associated with group A-like 
expression measured using EST (Fig. 1c).
However, such consistency was not observed when qPCR estimates of transcript quantity of individual var 
classes were compared with proportional expression estimated through EST (Fig. 1d). Though transcript quan-
tity of group A var genes was positively associated with group A-like expression estimated using EST, transcript 
quantity of group B and C var did not show expected negative associations with group A-like var or positive 
associations with cys4 (i.e. non-group A-like) var tags estimated using EST (Fig. 1d).
When the expression of different var subsets is calculated as a proportion of the total var transcript we implic-
itly make an assumption that individual parasites from different clinical isolates express equal total quantities of 
var transcript and simply make a choice in which var genes to express in a mutually exclusive manner. In this 
scenario, the difference in var expression patterns observed between isolates will be mainly due to differences 
in the proportion of parasites in the population expressing each var subset. If this had been the case, we would 
expect the transcript quantity of broad subsets of var within the bulk parasite population to be negatively corre-
lated with one another. However, there was no evidence for such a relationship (see gpA1 vs b1 or c2, Fig. 2a). If 
expressions of different classes of var genes do not show clear negative associations with one another, this would 
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suggest that the overall amount of var transcript in the parasite population can vary between isolates as has been 
suggested previously41.
Transcript quantity and proportional expression analyses differ because var gene expression 
varies globally. Relaxing the assumption of constant var expression levels between different isolates helps 
in the interpretation of the relationship between var expression and host immunity. Previous studies have shown 
that group A PfEMP1 are relatively conserved in comparison to non-group A PfEMP131–34,38. Consistent with this, 
proportional expression of group A var (gpA_prop) estimated by qPCR was negatively associated with IE anti-
bodies (breadth-ab) carried at the time of disease (Fig. 1a, column 2), whilst proportional expression of groups 
B and C together (bc_prop) are positively associated with IE antibodies (Fig. 1a, column 2). However, when 
transcript quantity rather than proportional expression was considered, negative associations with IE antibodies 
extended to most major var gene subsets measured (Fig. 1b, column 2). This suggests that, rather than only select-
ing against parasites expressing one group of var genes over another, antibodies carried by the host may select 
more globally against high var gene expression.
This apparent global reduction of var gene expression with increasing host antibodies appears to be distinct 
from a reduction in the diversity of var genes that are expressed within each isolate. We previously used Simpsons 
diversity index to measure the “var expression homogeneity, VEH” in these parasite isolates50. The relationship 
Figure 1. Comparisons of qPCR and EST methods of var expression analysis. Shown are Spearman’s rank 
correlation coefficients (rho) or the Mann-Whitney U test’s score (z). Mann-Whitney U test was used to test 
the difference between severe and non-severe malaria (negative z indicates positive association). Depth of 
the background shading represents the p-value as indicated in the key. Red background indicates positive 
associations and blue background indicate negative associations. Increasing statistical significance is shown 
as deeper colour. (a) Associations between the “proportional expression” of broad classes of var calculated 
from qPCR and parasite surface phenotype; roset (rosetting), heterologous (breadth-ab) and homologous 
(hom-ab) antibodies present at the time of disease, age of the children (age) and severity of the disease 
(severe). breadth-ab = a measure of the breadth of reactivity of each child’s antibodies present at the time of 
disease against infected erythrocytes of 8 heterologous P. falciparum clinical isolates, Homo-Ab = Antibodies 
against each child’s own parasite isolate. gpA_prop, dc8_prop, b1_prop and c1_prop = “proportional 
expression” of group A, dc8 , group B (b1) and C (c2) var genes respectively calculated from qPCR data. 
bc_prop = “proportional expression” of group B and C var genes together i.e bc_prop = (b1 + c2)/sum var 
transcript (see method section). (b) The relationship between “transcript quantity” of var subclasses determined 
using qPCR with parasite surface phenotype (rosetting), heterologous and homologous antibodies present at 
the time of disease, age and disease severity (as for (a)). Names of the primers listed in Table S1 were used to 
represent the “transcript quantity” of the different var subclasses. (c) Associations between the “proportional 
expressions” of broad classes of var genes calculated from qPCR data to equivalent EST proportions calculated 
from expressed sequence tag (EST). bs2_cp2 is a subset of cys2 that may include group B var genes63. 
(d) Associations between “transcript quantity” determined with the primers listed in Table S1 by qPCR and EST 
proportions. Group B (b1) and C (c2) transcript quantity did not show the expected negative association with 
group A-like or positive associations with cys4. N=191 except for roset and homo-ab where N=121.
www.nature.com/scientificreports/
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Figure 2. IE surface antibodies associated with global regulation of var gene expression. (a) Correlation 
matrix based on Spearman’s rank correlation coefficient test. Shown is the rho value and the background 
shading was done as described in Fig. 1. N = 111. (b) Principal component factor analysis of var expression 
(clinical cases only). Red; transcript quantity of the var subclasses represented using the names of the primers 
(Table S1), Light blue; PfSIR2 expression (Pfsir2a, Pfsir2b), Black; markers of gametocytogenesis (Pfap-2g, 
Pfs16). Factor loadings above or below 0.3 were considered significant (dashed lines). N = 182 (c) The 
relationship between predicted factor scores of factor1 and factor2 with rosetting, breadth of host antibodies, 
host age, and severity of the disease (N=182 except for roset and homo-ab where N=121). Shown is rho and z 
score derived from Spearman’s rank correlation and Mann-Whitney U tests respectively. Background colouring 
was done in accordance with the p-value as described in Figs 1 and 2 legends. (d) Same as Fig. 2b except 
N = 215 and includes data of parasites from 33 children with asymptomatic infection.
www.nature.com/scientificreports/
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between host antibodies and expressed var transcript quantity were independent of VEH in a regression analysis 
(Table S2).
We considered other possible causes of global variation in var gene expression. First, it is possible that varying 
commitment to gametocytogenes between parasite isolates may have led to global variation in var gene expres-
sion. Previous studies show that commitment to gametocytogenes is associated with an altered programme of 
expression of PfEMP151,52. Recent studies have further suggested that var expression is controlled globally by an 
epigenetic mechanism that is potentially linked to gametocytogenesis53,54. Second, previous studies have sug-
gested a role for two genes Pfsir2a and Pfsir2b in the epigenetic control of var gene expression44,45. One recent 
study has suggested that epigenetic dysregulation of var genes may be associated with severe malaria41.
We therefore explored the expression of var in relation to two genes involved in the epigenetic regulation of 
var genes, Pfsir2a and Pfsir2b41,44,45, two involved in early gametocyte differentiation, Pfap2-g46 and Pfs1647, and 
host IE surface antibodies carried at the time of disease. Pfsir2a was positively associated with the var transcript 
quantity amplified with the primers gpA1, gpA2, dc8-2, dc8-2, dc8-3, dc9, b1 and c2, and markers of gametocyte 
commitment (Pfap2-g and Pfs16) (Fig. 2a).
IE antibodies carried at the time of disease (breadth-ab) were negatively associated with Pfsir2a expression 
(p = 0.003, Fig. 2a) but not with Pfsir2b, Pfap2-g or Pfs16 expression. Previously, higher body temperature was 
suggested to positively influence Pfsir2 expression41. We found that body temperature shows marginal positive 
associations with Pfsir2 expression (Pfsir2a; rho = 0.18, p = 0.05, Pfsir2b; rho = 0.18, p = 0.05, N = 121). However 
when body temperature and IE surface antibody was used as explanatory variables in a regression analysis pre-
dicting Pfsir2a, only IE surface antibodies showed independent association with Pfsir2a expression (Table S3). 
Taken together these data support the idea that antibodies may play a role in negatively selecting parasites in 
vivo according to their broadly defined epigenetic state and suggests that this is independent of gametocyte 
commitment55.
Principal factor analysis. To explore these relationships further we used principal factor analysis to vis-
ualize measures of var gene expression in relation to the expression of genes related to the control of var gene 
expression; Pfsir2a and Pfsir2b, and early markers of gametocyte differentiation; Pfap2-g and Pfs16.
Two major factors were identified in the dataset. The majority of the variables were significantly associated 
with one of these factors (Table S4). The different variables in the dataset were plotted in Fig. 3a in relation to each 
factor. Factor 1 accounts for approximately 65.84% of the variation in the data and correlates with expression 
of group A, DC8 and DC13 var genes (Fig. 2b and Table S4). Factor 2, which accounts for a further 28.18% of 
the variation in the data was associated with expression of group B and C var genes, epigenetic regulator genes; 
Pfsir2a and Pfsir2b, and markers of sexual commitment; Pfap2-g and Pfs16 (Fig. 2b and Table S4). Group B var 
genes, and Pfap2-g clustered with Pfsir2 and were associated with factor 2 (Table S4). This raises the possibility 
that expression of group B var genes and Pfap2-g may be linked together through a shared epigenetic mechanism 
as suggested by their clustering with Pfsir2.
To explore this further, we tested the associations of the predicted factor scores (see method) with rosetting, 
breadth of host antibodies present at time of disease, host age, and severity of the disease. As expected factor1 
Figure 3. A hypothetical model for immunity dependent regulation of PfEMP1 expression. The black, 
blue and grey circles represent PfEMP1 variants expressed on the surface of the infected erythrocytes. (a–c) 
represents the response of parasites to partial immunity; (a) shows a hypothetical PfEMP1 expression profile 
within a naïve host where multiple PfEMP1 are expressed at high level to explore the host cytoadhesive space. 
Dominant variants are those which have a growth advantage due to their optimal cytoadhesion ability (b) 
antibody are raised first against the dominant variants (in this case the black type) (c) another variant (blue) 
previously expressed at lower frequency dominates the population. (d,e) represents the response of the parasite 
population in an individual carrying antibodies to a broad range of variants; (d) the pre-existing naturally 
acquired antibody clears all variants carrying high levels of PfEMP1, (e) A population of parasites expressing a 
previously recognised PfEMP1 but expressed at low levels of PfEMP1 survive and establish chronic infections.
www.nature.com/scientificreports/
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was associated with rosetting (p = 0.0001, Fig. 2c), however, both factor 1 and 2 were negatively associated with 
breadth of recognition by host antibodies present at the time of disease and positively associated with severity of 
disease (Fig. 2c). This is consistent with the idea that antibodies carried by the host may select globally against 
high var gene expression.
Parasites that establish chronic infections need to survive in the presence of antibodies that have been accu-
mulated prior to infection or developed during the course of the infection. In contrast, as a result of mosquito 
abundance, periods of high transmission lead to opportunities to infect naïve hosts or those that have not previ-
ously encountered that particular parasite genotype and carry low levels of antibody. The apparent global asso-
ciation of var gene expression with host antibodies described here may provide a simple external control for 
adaptation to these two essential phases in the parasite life cycle. To test this we extended this analysis to include 
var gene expression of parasites from asymptomatic individuals who carried infections towards the end of the low 
transmission season. The result of this extended data is consistent with that of the smaller dataset and clusters into 
two factors (Fig. 2d and Table S5). The predicted scores of both factors were negatively associated with breadth of 
host antibodies (factor 1; rho = − 0.4, p < 0.0001, factor2; rho = − 0.33, p < 0.0001, Spearman’s correlation test) 
and asymptomatic infection (factor1; z = 5.31, p < 0.0001, factor2; z = 6.7, p < 0.0001, Mann-Whitney U test). 
This result raises the possibility that parasites causing asymptomatic infections under conditions of high levels of 
circulating antibodies may exhibit lower var gene expression (Fig. S1). This may be part of a mechanism to avoid 
immune surveillance and promote chronic infection. Despite the clustering of Pfap2-g and Pfs16 expression with 
factor 2 , there was no evidence for a direct correlation between IE antibody breadth and expression of Pfap2-g 
(Fig. 2a). This does not support a direct modulation of gametocyte commitment by antibodies. It is none the less 
possible that our simple measure of the breadth of IE antibodies may not fully capture the immune selection 
pressure experienced by the parasite population at the time of infection.
To explore this further we considered “homologous” IE antibodies tested against cultured parasites from each 
child as a more direct measure of the immune pressure experienced by the infecting parasite population. There 
was a similar negative correlation between homologous IE antibodies and Pfsir2a and a marginal negative cor-
relation between homologous IE antibodies and Pfap2-g expression (Fig. 2a). Determining whether antibody 
responses to the infecting parasite population play a direct role in selecting parasites that have reduced commit-
ment to gametocytes will require a more extensive examination of the epigenetic state of cells that escape host 
antibodies.
In summary, the relatively independent expression of broad classes of var genes described here is consistent 
with a model (Fig. 3) that incorporates an extended parasite bet-hedging strategy in the face of host antibodies, in 
which var expression varies both in type and expression level. Such a strategy would potentially provide the para-
site population with a simple means to explore the host cytoadhesive space by simultaneously expressing multiple 
PfEMP1 subsets at high quantities when infecting naïve hosts56. As part of a form of “balancing act” between 1) 
retaining the cytoadhesion function of IE and 2) immune evasion, expression of low quantities of PfEMP1 may 
also provide means for extending within-host parasite survival when host antibodies against the infecting isolates 
are high. This might explain why asymptomatic infection often express group A-like PfEMP150 but at low quantity 
(Fig.S1). This simple strategy driven by host antibodies may operate both among clinical infections of children 
and in the establishment of chronic infections. This model would potentially clarify the possible roles of other 
multigene families known to be expressed on the surface of IE and that undergo antigenic variation. Pfsir2a is also 
involved in the regulation of rifin genes expression45. In future experiments it would be interesting to determine 
whether expression of rifins and stevor antigens are altered in parasites that express lower levels of PfEMP1 on 
the surface.
Material and Methods
Clinical characteristics of the patients. Patient samples used in this study were described in previous 
publications38,42,50,57. The children presented to Kilifi County Hospital with severe and non-severe malaria. Severe 
malaria is defined as a hospital admission with impaired consciousness (Blantyre coma score < 4 in patients 
under 8 months old; < 5 in patients ≥ 8months old)58, respiratory distress (deep “kussmaul” pattern of breath-
ing)59 or severe malarial anemia (hemoglobin < 5g/dl). Non-severe cases include children admitted to hospi-
tal or attending out patient department who do not present with any of the three severe syndromes described 
above. Asymptomatic cases are children that were slides positive for P. falciparum but no clinical signs before 
the beginning of malaria season. The samples used in this study (N = 215, severe = 85, non-severe = 97, asymp-
tomatic = 33) are restricted to those for which 1) sufficient sample material remained for further study 2) we 
previously obtained var expression data using the dblα -tag or expressed sequenced tags (EST) analysis method 
and 3) a measure had been previously made of the breadth of IE surface antibodies response present at the time 
of disease38,42. These samples were collected between 2003–2007.
Ethics statement. Ethical approval for this study was obtained from Kenya Medical Research Institute 
(KEMRI) Ethical Review Committee (under SSC 1131), and written informed consent was obtained from par-
ents/guardians of the study participants. The study methods were carried out in accordance with the approved 
guidelines.
RNA and cDNA preparations. RNA and cDNA preparation of the samples used in this study was described 
previously38.
Rosetting and IE surface antibody. Rosette frequency and IE surface antibody data was obtained and 
published previously42. Rosetting data was described in ref. 42. IE surface antibody data was described in refs 
www.nature.com/scientificreports/
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38,42. Homologous antibody levels were also measured50 whereby each child’s plasma was tested against that 
child’s own infecting parasite matured in vitro to mid to late trophozoite stage. These data was previously pub-
lished in ref. 50.
Var expression analysis. a) Expressed sequence tag (EST) sequencing approach. This data is previously 
published in ref. 38. Degenerate primers were used to PCR amplify a region within the DBLα -domain that is 
highly conserved in the majority of var genes, cloned into TOPO® -TA cloning vector, transformed into E. coli, 
and up to 96 colonies from each sample sequenced. The sequences were classified as described in38,42 and counted 
for each sample. EST proportional expression scores were obtained by counting the proportion of sequences 
within each sample that fell within each of the sequence groups. Group A-like tags were defined as those that had 
two cysteines (cys2) and carried one of a set of sequence blocks38.
b) Var transcript quantification using RT-PCR. Recently, 23 conserved domain cassettes (DCs) have been iden-
tified in PfEMP127. Primers targeting these domain cassettes were subsequently developed and used to quan-
tify their expression in parasites from children with severe and non-severe malaria40. For the present study, we 
selected a subset of these primers that showed differential expression between severe and non-severe malaria. 
These included four primers targeting DC8 (named dc8-1, dc8-2, dc8-3, dc8-4), one primer for each of DC13 
(dc13), DC4 (dc4), and DC9 (dc9), two primers targeting the majority of group A var genes (gpA1 and gpA2) 
(Table S1). We also quantified the expression of group B (b1) and C (c2) var genes using primers described in37 
targeting the 5′ -untranslated region of the var classes (Table S1). In addition we quantified the expression of 
two genes involved in epigenetic control of var gene expression, Pfsir2a and Pfsir2b, and two markers of early 
gametocytes commitment, Pfap2-g46 and Pfs1647. We chose two housekeeping genes, Seryl tRNA synthetase and 
Fructose bisphosphate aldolase40,60,61 to use for relative quantification of the expressed var genes. We included dc9 
targeting primer on the basis that dc9 was previously shown to be up-regulated in non-severe compared to severe 
malaria cases40. Before real-time PCR was carried out, the amplification efficiency of the primers was determined 
by generation of standard curves over 5 logs (100ng to 10pg of IT gDNA). The primers all had above 90% amplifi-
cation efficiency. For the real time quantitative PCR, the PCR reaction and cycling conditions were carried out as 
described in40 with the Applied Biosystems 7500 Real-time PCR system. We set the cycle threshold (Ct) at 0.025. 
Controls with no template were included at the end of each batch of 22 samples per primer and the melt-curves 
analysed for non-specific amplification. We used genomic DNA from the IT4 laboratory parasite line at 10ng/μ l 
as a standard sample included in all plates because we were able to successfully amplify this line using all the 
primers used in this study. To estimate the “transcript quantity” the ∆∆ct relative quantification method was used 
to calculate the arbitrary transcript unit (Tus) using the formula (Tus = 2(5−∆∆ct)). However, we also estimated “pro-
portional expression” of the transcripts within each sample (see below). When calculating proportional expres-
sion from qPCR the ∆∆ct was not appropriate and we instead used Tus calculated as described in Lavstsen et al.40 
i.e. 2(5−∆ct). We assigned a zero Tus value if a reaction did not result in detectable amplification after 40 cycles of 
amplification, i.e if the Ct value was undetermined. We excluded from the analysis if amplification of either seryl 
tRNA synthetase or fructose biphosphate aldose could not be obtained.
Statistical analysis. To calculate the “proportional expression” of each var gene subset, we summed the 
transcript quantity of all the var subset analysed using the primers listed in table S1 (sum var transcript). The 
proportion contributed by each subset was then calculated. Since expression of group A and DC8 var subsets were 
each quantified using four different primers (Table S1), the median transcript quantity measured by these sets of 
group A and DC8 targeting primers was used to represent group A and DC8 respectively in the calculation of sum 
var transcript quantity and proportions. The sum of the transcript quantity of the var subsets was first obtained 
as follows; sum var transcript = group A_median + dc8_median + b1 + c2. The proportion of each subset was 
then calculated as follows; gpA_prop = group A_median/sum var transcript, dc8_prop = dc8_median/sum var 
transcript, b1_prop = b1/sum var transcript, c2_prop = c2/sum var transcript and bc_prop = (b1 + c2)/sum var 
transcript. Correlations between variables were evaluated using Spearman’s rank correlation coefficient or the 
2-sample Wilcoxon rank-sum (Mann-Whitney) test.
Principal factor analysis. To visualize the relationships between the multiple variables and identify poten-
tial clusters of variables, we used principal factor analysis. We first checked whether our variables are factorable. 
We examined the factorability of the data using Kaiser-Meyer-Olkin (KMO) tests. KMO tests the adequacy of 
the data for factorial analysis and KMO above 0.6 is considered adequate62. To optimize the factor loadings (the 
relationship of each variable to the factors) and obtain simple structures where the variables are significantly 
associated with one of the factors and poorly on the others, the loadings were rotated using the promax rotation 
method and loading > 0.3 or < − 0.3 was considered significant. We used promax because it resulted in the best 
defined structure with the majority of variables loading above 0.3 or below − 0.3.
We used the Stata command “predict” to generate predicted factor scores for each individual. We then tested 
the relationship between rosetting, breadth of host antibodies, severity of the disease, asymptomatic infection and 
the factor scores using Spearman’s rank correlation coefficient and Mann-Whitney U tests.
To eliminate zeros from the Tus data we added 0.1 to all values and then log transformed the resultant Tus 
values to normalize the distribution of the data before use in factor analysis. All statistical tests were performed 
using Stata software version 13 (Stata Corp, College Station, Tx).
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